Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2020 / Cilt: 28 - Sayı: 4

Impact of sarcopenia in aortoiliac occlusive disease in Mediterranean population

Akdeniz popülasyonunda aortoiliyak tıkayıcı hastalıkta sarkopeninin etkisi

Pages
615–622
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a statistically significant difference in the one-year survival rate (p=0.003 and p=0.291, respectively) and major adverse cardiovascular and cerebrovascular events (p=0.005 and p=0.206, respectively) for total psoas area compared to psoas muscle density.Conclusion:­Total psoas area shows a prognostic value for survival and major adverse cardiovascular and cerebrovascular events in this patient population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background:­This study aims to validate the psoas muscle area and psoas muscle density as morphometric predictors in cardiovascular and cerebrovascular endpoints in patients with extensive aortoiliac peripheral arterial disease.Methods: A total of 57 patients (55 males, 2 females; mean age 60±8.2 years; range, 35 to 83 years) with Trans-Atlantic Inter-Society Consensus type D lesions who underwent revascularization at two Portuguese tertiary hospitals between January 2013 and July 2019 were retrospectively analyzed.
📊
Key Findings & Data:The patients with a recent (<6 months) computed tomography scan prior to the revascularization procedure were included in the study.
💡
Conclusion & Impact:There was a statistically significant difference in the one-year survival rate (p=0.003 and p=0.291, respectively) and major adverse cardiovascular and cerebrovascular events (p=0.005 and p=0.206, respectively) for total psoas area compared to psoas muscle density.Conclusion:­Total psoas area shows a prognostic value for survival and major adverse cardiovascular and cerebrovascular events in this patient population.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Background:­This study aims to validate the psoas muscle area and psoas muscle density as morphometric predictors in cardiovascular and cerebrovascular endpoints in patients with extensive aortoiliac peripheral arterial disease.Methods: A total of 57 patients (55 males, 2 females; mean age 60±8.2 years; range, 35 to 83 years) with Trans-Atlantic Inter-Society Consensus type D lesions who underwent revascularization at two Portuguese tertiary hospitals between January 2013 and July 2019 were retrospectively analyzed. The patients with a recent (<6 months) computed tomography scan prior to the revascularization procedure were included in the study. Both centers offered to their patients open and endovascular repair of aortoiliac peripheral arterial disease. Major adverse cardiovascular and cerebrovascular events and major adverse limb events were evaluated.Results:­The median follow-up was 20 months. The mean survival rate was 93±3.4% at 30 days and 62.7±8.6% at 48 months. The discriminative thresholds found in this population were 2,175.8 mm2for total psoas area and 51.75 Hounsfield unit for psoas muscle density. There was a statistically significant difference in the one-year survival rate (p=0.003 and p=0.291, respectively) and major adverse cardiovascular and cerebrovascular events (p=0.005 and p=0.206, respectively) for total psoas area compared to psoas muscle density.Conclusion:­Total psoas area shows a prognostic value for survival and major adverse cardiovascular and cerebrovascular events in this patient population.

Özet

Amaç: Bu çalışmada yaygın aortoiliyak perifer arter hastalığı olan hastalarda kardiyovasküler ve serebrovasküler sonlanım noktalarında morfometrik öngördürücüler olarak psoas kas alanı ve psoas kas dansitesinin doğrulanması amaçlandı.Ç a ­l ı ş ­m a­ p l a ­n ı :­Ocak 2013 - Temmuz 2019 tarihleri arasında Portekiz merkezli iki üçüncü basamak hastanede revaskülarizasyon yapılan Transatlantik Toplulukları Fikir Birliği tip D lezyonlu toplam 57 hasta (55 erkek, 2 kadın; ort. yaş 60±8.2 yıl; dağılım, 35-83 yıl) retrospektif olarak incelendi. Çalışmaya revaskülarizasyon işleminden önce yakın zamanda (<6 ay) bilgisayarlı tomografi sonucu olan hastalar alındı. Her iki merkezde de, hastalara aortoiliyak periferik arter hastalığının açık ve endovasküler tamiri önerildi. Majör advers kardiyovasküler ve serebrovasküler olaylar ve majör advers ekstremite olayları değerlendirildi.Bul gu lar: Medyan takip süresi 20 ay idi. Ortalama sağkalım oranı 30. günde %93±3.4 ve 48. ayda %62.7±8.6 idi. Bu popülasyonda tespit edilen ayırıcı eşik değerler, total psoas alanı için 2,175.8 mm2ve psoas kas dansitesi için 51.75 Hounsfield unit idi. Bir yıllık sağkalım oranı (sırasıyla p=0.003 ve p=0.291) ve majör advers kardiyovasküler ve serebrovasküler olaylar (sırasıyla p=0.005 ve p=0.206) açısından, psoas kas dansitesine kıyasla, total psoas alanı için istatistiksel olarak anlamlı bir fark izlendi.S o ­n u ç :­Total psoas alanı, bu hasta popülasyonunda sağkalım ve majör advers kardiyovasküler ve serebrovasküler olaylar için prognostik değere sahiptir.

🔖

Cite This Article

Pereira-NEVES, A., Dias-NETO, M., Rocha-NEVES, J., BARROS, D., Duarte-GAMAS, L., CERQUEİRA, A., VİDOEDO, J., TEİXEİRA, J. (2022). Impact of sarcopenia in aortoiliac occlusive disease in Mediterranean population. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 28 - Sayı: 4, 615–622. https://ajindex.com/articles/423666

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Reeve TE 4th, Ur R, Craven TE, Kaan JH, Goldman MP, Edwards MS, et al. Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia. J Vasc Surg 2018;67:1512-20.
  2. Ghaffarian AA, Foss WT, Donald G, Kraiss LW, Sarfati M, Griffin CL, et al. Prognostic implications of diagnosing frailty and sarcopenia in vascular surgery practice. J Vasc Surg 2019;70:892-900.
  3. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019;393:2636-46.
  4. Amini N, Spolverato G, Gupta R, Margonis GA, Kim Y, Wagner D, et al. Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia. J Gastrointest Surg 2015;19:1593-602.
  5. Drudi LM, Phung K, Ades M, Zuckerman J, Mullie L, Steinmetz OK, et al. Psoas muscle area predicts all-cause mortality after endovascular and open aortic aneurysm repair. Eur J Vasc Endovasc Surg 2016;52:764-9.
  6. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010;211:271-8.7. Haymana C, Safer U. Measurement of cross-sectional area of the psoas for sarcopenia. Colorectal Dis 2015;17:172. Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis 2015;17:O20-6. Juszczak MT, Taib B, Rai J, Iazzolino L, Carroll N, Antoniou GA, et al. Total psoas area predicts medium-term mortality after lower limb revascularization. J Vasc Surg 2018;68:1114-25.e1. Lyon TD, Farber NJ, Chen LC, Fuller TW, Davies BJ, Gingrich JR, et al. Total psoas area predicts complications following radical cystectomy. Adv Urol 2015;2015:901851. Mamane S, Mullie L, Piazza N, Martucci G, Morais J, Vigano A, et al. Psoas muscle area and all-cause mortality after transcatheter aortic valve replacement: The montreal-munich study. Can J Cardiol. 2016 Feb;32(2):177-82.
  7. Harada K, Suzuki S, Ishii H, Aoki T, Hirayama K, Shibata Y, et al. Impact of skeletal muscle mass on long-term adverse cardiovascular outcomes in patients with chronic kidney disease. Am J Cardiol 2017;119:1275-80.
  8. Yamashita M, Kamiya K, Matsunaga A, Kitamura T, Hamazaki N, Matsuzawa R, et al. Prognostic value of psoas muscle area and density in patients who undergo cardiovascular surgery. Can J Cardiol 2017;33:1652-9.
  9. Miller BS, Ignatoski